DiaSorin S.p.A. (BIT:DIA)
95.38
-1.42 (-1.47%)
May 9, 2025, 5:35 PM CET
DiaSorin Revenue
DiaSorin had revenue of 313.00M EUR in the quarter ending March 31, 2025, with 8.30% growth. This brings the company's revenue in the last twelve months to 1.21B, up 5.42% year-over-year. In the year 2024, DiaSorin had annual revenue of 1.19B with 3.24% growth.
Revenue (ttm)
1.21B
Revenue Growth
+5.42%
P/S Ratio
4.31
Revenue / Employee
368.84K
Employees
3,308
Market Cap
5.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.19B | 37.22M | 3.24% |
Dec 31, 2023 | 1.15B | -212.93M | -15.64% |
Dec 31, 2022 | 1.36B | 123.48M | 9.98% |
Dec 31, 2021 | 1.24B | 356.35M | 40.43% |
Dec 31, 2020 | 881.31M | 174.99M | 24.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.34B |
Amplifon | 2.42B |
Philogen | 77.65M |
EL.En. | 565.85M |
Pharmanutra | 116.15M |
Garofalo Health Care | 467.77M |
Safilo Group | 993.22M |
GPI S.p.A. | 509.93M |
DiaSorin News
- 7 days ago - DiaSorin: Anticipate A Double-Digit EBITDA Growth Rate - Seeking Alpha
- 7 weeks ago - Full Year 2024 DiaSorin SpA Earnings Call Transcript - GuruFocus
- 7 weeks ago - DiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Italy's DiaSorin ex-Covid revenue in line with guidance - Reuters
- 5 months ago - DiaSorin S.p.A. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Diasorin SpA (WBO:DIAS) Q3 2024 Earnings Call Highlights: Strong Growth Amidst Challenges - GuruFocus
- 6 months ago - Diagnostics group DiaSorin's nine-month adjusted core profit up 6% - Reuters
- 10 months ago - DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript - Seeking Alpha